Published in
Taylor and Francis Group, Leukemia & Lymphoma, 6(63), p. 1363-1368, 2022
DOI: 10.1080/10428194.2022.2030475
Links
Tools
Incidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experience
Journal article published in 2022 by
Megan Melody,
Sangeetha Gandhi,
Hollie Saunders,
Zaid Abdel-Rahman,
Jacquelyn Hastings,
Paula Lengerke Diaz 
,
Nicole Gannon,
Tuan Truong,
Matthew Hathcock,
Arushi Khurana,
Patrick Johnston,
Stephen Ansell,
Nora Bennani ,
Jonas Paludo ,
Jose Villasboas Bisneto
and other authors.
,
Nicole Gannon,
Tuan Truong,
Matthew Hathcock,
Arushi Khurana,
Patrick Johnston,
Stephen Ansell,
Nora Bennani ,
Jonas Paludo ,
Jose Villasboas Bisneto
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 